Home » Stocks » NEPH

Nephros, Inc. (NEPH)

Stock Price: $7.93 USD -0.06 (-0.75%)
Updated May 13, 2021 2:23 PM EDT - Market closed
After-hours: $8.14 +0.21 (2.65%) May 13, 4:00 PM
Market Cap 81.09M
Revenue (ttm) 8.77M
Net Income (ttm) -4.21M
Shares Out 9.96M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $7.93
Previous Close $7.99
Change ($) -0.06
Change (%) -0.75%
Day's Open 7.95
Day's Range 7.93 - 8.15
Day's Volume 6,519
52-Week Range 5.08 - 9.12

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 57.14% and 1.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

6 days ago - Zacks Investment Research

Net Revenue of $2.7 Million; Highest First Quarter in Company History

1 week ago - GlobeNewsWire

SOUTH ORANGE, NJ, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter financial ...

2 weeks ago - GlobeNewsWire

Anticipates Net Revenue of $2.7 Million; Highest First Quarter in Company History

1 month ago - GlobeNewsWire

SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the me...

1 month ago - GlobeNewsWire

SOUTH ORANGE, NJ, March 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --  Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the m...

2 months ago - GlobeNewsWire

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 33.33% and 1.92%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Nephros (NASDAQ:NEPH) were flat after the company reported Q4 results. Quarterly Results Earnings per share fell 300.00% over the past year to ($0.08), which beat the estimate of ($0.11).

2 months ago - Benzinga

Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third Quarter Full Year Revenue $8.6 million, Down 17% Against Prior Year

2 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Feb. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the med...

2 months ago - GlobeNewsWire

Nephros Inc. (NEPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

SOUTH ORANGE, NJ, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the med...

2 months ago - GlobeNewsWire

Anticipates $2.3 Million Revenue in Fourth Quarter, $8.5 Million in Full-Year; Quarterly Revenue Grew 9% Sequentially Over Third Quarter; Full Year Revenue Declined 17%

4 months ago - GlobeNewsWire

HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021

4 months ago - GlobeNewsWire

HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021

4 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and p...

6 months ago - GlobeNewsWire

Finance Veteran Strengthens Management Team; Quarter-over-Quarter Net Revenue up 34%; Year-over-Year down 31%

6 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire  -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and...

6 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance wat...

6 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --  Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products an...

7 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 07, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and...

7 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and p...

7 months ago - GlobeNewsWire

  Daron Evans to Remain Senior Science Advisor and CEO of Specialty Renal Products

8 months ago - GlobeNewsWire

Nephros, Inc. (NEPH) CEO Daron Evans on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

SOUTH ORANGE, NJ, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Net Revenue down 32% due to COVID-19 Interruptions

9 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, July 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells water purification products and pathogen detect...

9 months ago - GlobeNewsWire

  Nephros SequaPath™, a new microbial screening system, used to evaluate 88 building water samples across four US geographic regions

9 months ago - GlobeNewsWire

SOUTH ORANGE, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH ), a commercial-stage company that develops and sells high performance water purification produ...

10 months ago - GlobeNewsWire

Anticipates $1.6 Million Net Revenues

10 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, June 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and ...

10 months ago - GlobeNewsWire

SOUTH ORANGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH ), a commercial-stage company that develops and sells high performance water purification produ...

11 months ago - GlobeNewsWire

Executives to Present Business Overviews

1 year ago - GlobeNewsWire

Product Revenue up 43% over Q1 2019

1 year ago - GlobeNewsWire

Nephros has been struggling lately, but the selling pressure may be coming to an end soon.

1 year ago - Zacks Investment Research

Anticipates $2.6 Million Net Revenues, Approximately 45% Growth Over 2019

1 year ago - GlobeNewsWire

Medical Device Veteran Hired to Drive FDA Clearance and Market Launch

1 year ago - GlobeNewsWire

SOUTH ORANGE, NJ, March 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products an...

1 year ago - GlobeNewsWire

Nephros, Inc. (NEPH) CEO Daron Evans on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

SOUTH ORANGE, NJ, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products an...

1 year ago - GlobeNewsWire

SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a  commercial-stage company that develops and sells high performance w...

1 year ago - GlobeNewsWire

SOUTH ORANGE, NJ, Jan. 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products an...

1 year ago - GlobeNewsWire

Anticipates $10.3 Million Full-Year Revenue, Approximately 82% Growth Over 2018; Fourth Quarter Year-Over-Year Revenue Growth Approximately 99%

1 year ago - GlobeNewsWire

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: CERS, NOG, SYRS, ZNGA
1 year ago - 24/7 Wall Street

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Sep 21, 2004
Stock Exchange
NASDAQ
Ticker Symbol
NEPH
Full Company Profile

Financial Performance

In 2020, Nephros's revenue was $8.56 million, a decrease of -17.16% compared to the previous year's $10.33 million. Losses were -$4.77 million, 39.4% more than in 2019.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Nephros stock is "Buy." The 12-month stock price forecast is 13.83, which is an increase of 74.40% from the latest price.

Price Target
$13.83
(74.40% upside)
Analyst Consensus: Buy